Suivre
Pierre-Louis Toutain
Titre
Citée par
Citée par
Année
The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibiotics
PL Toutain, JRE Del Castillo, A Bousquet-Mélou
Research in veterinary science 73 (2), 105-114, 2002
4422002
Pharmacodynamics and pharmacokinetics of nonsteroidal anti‐inflammatory drugs in species of veterinary interest
P Lees, MF Landoni, J Giraudel, PL Toutain
Journal of veterinary pharmacology and therapeutics 27 (6), 479-490, 2004
3682004
Plasma terminal half‐life
PL Toutain, A Bousquet‐mélou
Journal of veterinary pharmacology and therapeutics 27 (6), 427-439, 2004
3662004
Plasma clearance
PL Toutain, A Bousquet‐mélou
Journal of veterinary pharmacology and therapeutics 27 (6), 415-425, 2004
3192004
Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure
JA Taylor, FS Vom Saal, WV Welshons, B Drury, G Rottinghaus, PA Hunt, ...
Environmental health perspectives 119 (4), 422-430, 2011
3162011
Bioavailability and its assessment
PL Toutain, A Bousquet‐mélou
Journal of veterinary pharmacology and therapeutics 27 (6), 455-466, 2004
3012004
Species differences in pharmacokinetics and pharmacodynamics
PL Toutain, A Ferran, A Bousquet-Mélou
Comparative and veterinary pharmacology, 19-48, 2010
2612010
Volumes of distribution
PL Toutain, A Bousquet‐mélou
Journal of veterinary pharmacology and therapeutics 27 (6), 441-453, 2004
2552004
Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine
PL Toutain, P Lees
Journal of veterinary pharmacology and therapeutics 27 (6), 467-477, 2004
2382004
Holding thermal receipt paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of bisphenol A (BPA)
AM Hormann, FS Vom Saal, SC Nagel, RW Stahlhut, CL Moyer, ...
PloS one 9 (10), e110509, 2014
2222014
The pharmacokinetics of xylazine hydrochloride: an interspecific study
R GARCIA‐VILLAR, PL Toutain, M Alvinerie, Y Ruckebusch
Journal of veterinary pharmacology and therapeutics 4 (2), 87-92, 1981
2001981
Plasma exogenous creatinine clearance test in dogs: comparison with other methods and proposed limited sampling strategy
ADJ Watson, HP Lefebvre, D Concordet, V Laroute, JP Ferré, JP Braun, ...
Journal of Veterinary Internal Medicine 16 (1), 22-33, 2002
1792002
Comparative pharmacokinetics of doramectin and ivermectin in cattle
PL Toutain, DW Upson, TN Terhune, ME McKenzie
Veterinary Parasitology 72 (1), 3-8, 1997
1591997
Creatine kinase in the dog: a review
M Aktas, D Auguste, HP Lefebvre, PL Toutain, JP Braun
Veterinary research communications 17, 353-369, 1993
1531993
Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine
PL Toutain
Aaps Pharmsci 4, 160-188, 2002
1442002
High bioavailability of bisphenol A from sublingual exposure
V Gayrard, MZ Lacroix, SH Collet, C Viguié, A Bousquet-Melou, ...
Environmental health perspectives 121 (8), 951-956, 2013
1382013
Comparison of pharmacokinetic profiles of doramectin and ivermectin pour-on formulations in cattle
V Gayrard, M Alvinerie, PL Toutain
Veterinary Parasitology 81 (1), 47-55, 1999
1381999
Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling
PL Toutain, A Autefage, C Legrand, M Alvinerie
Journal of veterinary pharmacology and therapeutics 17 (6), 459-469, 1994
1331994
Should oral gavage be abandoned in toxicity testing of endocrine disruptors?
LN Vandenberg, WV Welshons, FS Vom Saal, PL Toutain, JP Myers
Environmental Health 13 (1), 1-7, 2014
1292014
Intestinal secretion is a major route for parent ivermectin elimination in the rat
CM Laffont, PL Toutain, M Alvinerie, A Bousquet-Mélou
Drug metabolism and disposition 30 (6), 626-630, 2002
1292002
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20